Abstract
Objective: Quantifying risk for cardiovascular disease (CVD) events among adolescents is difficult owing to the long latent period between risk factor development and disease outcomes. This study examined the 30-year CVD event risk among adolescents with severe obesity treated with and without metabolic and bariatric surgery (MBS), compared with youths with moderate obesity, overweight, or normal weight. Methods: Cross-sectional and longitudinal comparisons of five frequency-matched (age and diabetes status) groups were performed: normal weight (n = 247), overweight (n = 54), obesity (n = 131), severe obesity without MBS (n = 302), and severe obesity undergoing MBS (n = 215). A 30-year CVD event score developed by the Framingham Heart Study was the primary outcome. Data are mean (SD) with differences between time points for MBS examined using linear mixed models. Results: Preoperatively, the likelihood of CVD events was higher among adolescents undergoing MBS (7.9% [6.7%]) compared with adolescents with severe obesity not referred for MBS (5.5% [4.0%]), obesity (3.9% [3.0%]), overweight (3.1% [2.4%]), and normal weight (1.8% [0.8%]; all P < 0.001). At 1 year after MBS, event risk was significantly reduced (7.9% [6.7%] to 4.0% [3.4%], P < 0.0001) and was sustained for up to 5 years after MBS (P < 0.0001, all years vs. baseline). Conclusions: Adolescents with severe obesity are at elevated risk for future CVD events. Following MBS, the predicted risk of CVD events was substantially and sustainably reduced.
Original language | English (US) |
---|---|
Pages (from-to) | 616-623 |
Number of pages | 8 |
Journal | Obesity |
Volume | 28 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2020 |
Funding
Funding for Teen‐LABS was provided by the NIH (U01DK072493/UM1 DK072493 to THI) and the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH (8UL1TR000077). Support also came from the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH (UL1TR000114). Nonsurgical comparison cohorts were provided in part by funding from NIH grants F32‐HL127881 (JRR), R01‐HL110957 (ASK), and R01‐HL105591 (EMU). Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the NIH award number UL1TR000114 (JRR).
ASJC Scopus subject areas
- Endocrinology
- Nutrition and Dietetics
- Medicine (miscellaneous)
- Endocrinology, Diabetes and Metabolism